Hotline: 1800 102 2007
X
Search Business Opportunities
Mar, 22 2019

J&J enters into agreement with Monash University to advance novel technology

The agreement has been signed between both of them to advance the development of an inhaled version of oxytocin in order to help prevent and manage Post-Partum Hemorrhage (PPH).

Janssen Pharmaceutica N.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has signed a sponsored research agreement with the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University.

The agreement has been signed between both of them to advance the development of an inhaled version of oxytocin in order to help prevent and manage Post-Partum Hemorrhage (PPH).

Jaak Peeters, Global Head, Johnson & Johnson Global Public Health, Janssen-Cilag GmBH, said, “When you consider the lifetime risk of dying for a woman in childbirth is 23 times higher in resource-limited settings than anywhere else you must act if you have the scientific capabilities to potentially help overcome that inequity. We hope to address this significant unmet need by helping accelerate the development of what would be a truly life-saving innovation and give women and their families everywhere the same chance at life.”

Michelle McIntosh, Monash Institute of Pharmaceutical Sciences, Monash University, added, “This is an exciting opportunity to expand this collaboration between industry and academia to develop an important healthcare innovation that aims to address a critical unmet medical need. There is a massive ripple effect when a mother dies – it's a very significant burden for these families and communities, and we are committed to bringing the gold-standard care to all mothers.”

Kathy Connell, Senior Director, New Ventures, Australia & New Zealand, Johnson & Johnson Innovation, further stated, “This latest agreement between Johnson & Johnson and Monash University, an internationally renowned leader in pharmacy and pharmacology, builds on our legacy of innovative academic-industry collaborations in Australia focused on developing life-saving treatments for the highest unmet needs.”

Comment
image
Related opportunities
  • Others Dealers And Distributors
    About Us: Mad About Dogs (MAD), an ambitious venture of Mad..
    Locations looking for expansion Delhi
    Establishment year 2006
    Franchising Launch Date 2018
    Investment size Rs. 10lac - 20lac
    Space required 400
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Baby and Kids Apparel, Children Garments
    About Us: Established in 2018, we at Mini Mint Kids deal..
    Locations looking for expansion Telangana
    Establishment year 2018
    Franchising Launch Date 2019
    Investment size
    Space required 900
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquater Hyderabad Telangana
  • Precious Jewellery
    About Us: Established in 1993 in Uttarakhand, Silveria Jewellers is India's..
    Locations looking for expansion Delhi
    Establishment year 1993
    Franchising Launch Date 2018
    Investment size Rs. 1 Cr. - 2 Cr
    Space required 300
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Bike Showroom
    About Us: CREDR is India's largest integrated eco system forused/ second..
    Locations looking for expansion New Delhi
    Establishment year 2015
    Franchising Launch Date 2017
    Investment size Rs. 30lac - 50lac
    Space required 1000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Delhi New Delhi
Insta-Subscribe to
Entrepreneur
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities